International Journal of Gynecology & Obstetrics · 2002 · 58 citations · 16 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicineObstetric ComplicationsObstetric HemorrhageCoagulation AbnormalitiesFetal OutcomesMaternal Medical Complications In PregnancyPregnancyPrevention Of Obstetric HemorrhageRisk Factors For Obstetric HemorrhageAnticoagulant Use In PregnancyAnticoagulation In PregnancyObstetric ThromboprophylaxisPregnancy-associated ThromboprophylaxisPregnancy-related Anticoagulation
OBJECTIVES: To examine if fetal risks associated with Warfarin anticoagulation during pregnancy may have been over-estimated at the time the drug was contraindicated during pregnancy. METHODS: Seven case series with the same therapeutic objective for Warfarin anticoagulation published after 1980 were identified. The frequencies of fetal complications were calculated and compared with those of the 1980 compilation. RESULTS: The frequencies of embryopathy, stillbirths, and neonatal deaths were similar to the 1980 database, but higher with respect to spontaneous abortions (24.1 vs. 8.6%) and premature deliveries (13.9 vs. 4.6%), and lower regarding live births (73.3 vs. 83.7%). CONCLUSIONS: Fetal risks associated with Warfarin anticoagulation during pregnancy have not been overestimated. Warfarin should not be given in cases where other anticoagulants do not increase the risk for the expecting mother.
16
Outcome of pregnancy in women with valve prostheses.
Eftihia Sbarouni, C M Oakley · Heart · 1994 · 307 citations · Full text
Medicine, Cardiology, Obstetrics +14
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
J. Hirsh, J. E. Dalen, D. Deykin et al. · CHEST Journal · 1992 · 121 citations